SID 2026Abstract 0861
Checkpoint inhibitor outcomes in melanoma are not driven by biologic sex in a large single center cohort
Richmond RL, Micevic G
SID Annual Meeting 2026Pigmentation & melanomaChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Skin cancer & tumorsMelanoma & molesBiologicsCancer drugs
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.892 · Not in PubMed: details from Crossref